Primary and Adjunctive Uses of Botulinum Toxin Type A in the Periorbital Region

Otolaryngologic Clinics of North America

Volumn 40, Issue 2, 2007, Pages 291-303

  Balikian, Richard V ^a   Zimbler, Marc S ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

BLEPHAROSPASM; DENERVATION; DYSTONIA; EYEBROW; EYELID; FACE SURGERY; HUMAN; ORBICULARIS OCULI MUSCLE; ORBIT; PARALYSIS; PTOSIS; REVIEW; RHYTIDOPLASTY;

EID: 33947316934     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2006.11.005     Document Type: Review

References (19)

1. Ahn M.S., Catten M., and Maas C.S. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 105 (2000) 1129-1135
2. Carruthers J., Fagien S., and Matarasso S.L. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114 6 Suppl (2004) 1S-22S
3. Zimbler M.S., and Nassif P.S. Adjunctive applications of botulinum toxin in facial aesthetic surgery. Plastic Surg Clin North Am 11 4 (2003) 477-482
4. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 103 2 (1999) 701-713
5. Schantz E.J., and Scott A.B. Use of crystalline type A botulinum toxin in medical research. In: Lewis G.E. (Ed). Biomedical aspects of botulism (1982), Academic Press, New York 143-149
6. Chen A.H., and Frankel A.S. Altering brow contour with botulinum toxin. Facial Plast Surg Clin North Am 11 4 (2003) 457-464
7. Carruthers J., and Carruthers A. Treatment of glabellar frown lines with C botulinum exotoxin. J Dermatol Surg Oncol 18 (1992) 17-21
8. Alderson K., Holds J.B., and Anderson R.L. Botulinum induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41 (1991) 1800-1805
9. Fagien S., and Brandt F.S. Primary and adjunctive use of botulinum toxin type A (Botox) in facial surgery. Clin Plast Surg 28 (2001) 127
10. Blitzer A., and Binder W.J. Cosmetic uses of botulinum neurotoxin type A: an overview. Arch Facial Plast Surg 4 (2002) 214-220
11. Fagien S. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg 112 5 (2003) 6S-18S
12. Choi J.C., Lucarelli M.J., and Shore J.W. Use of botulinum toxin in patients with high risk of wound complications following eyelid reconstruction. Ophthal Plast Reconstr Surg 13 (1997) 259
13. Isse N.G. Endoscopic facial rejuvenation: endoforehead the functional lift. Aesthetic Plast Surg 18 (1994) 21
14. Frankel A.S., and Kamer F.M. Chemical browlift. Arch Otolaryngol Head Neck Surg 124 (1998) 321-323
15. Scott A., Kennedy R.A., and Stubbs H.A. Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103 (1985) 347
16. Fagien S. Temporary management of upper lid ptosis, lid malposition, and eyelid fissure asymmetry with botulinum toxin type A. Plast Reconstr Surg 114 7 (2004) 1892-1902
17. Uddin J.M., and Davies P.D. Treatment of upper eyelid retraction associated with subconjunctival botulinum toxin injection. Ophthalmology 109 6 (2002) 1183-1187
18. Zimbler M.S., Holds J.B., and Kokoska M.S. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Facial Plast 165 3 (2001) 165-169
19. Klein A.W. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg 29 5 (2003) 549-556